|
Dimitrieva O.V., Tarasova L.V., Babokin V.E., Trofimov N.A.
Laboratory markers for the risk of pulmonary embolism development in patients with malignant neoplasms
|
№7 / 2023
|
|
Larina V.N., Karpenko D.G., Serova E.N., Ryzhikh A.A., Tyazhelnikov A.A.
Pulmonary thromboembolism in a young female patient due to the novel coronavirus infection
|
№10 / 2022
|
|
Tarasova L.V., Dimitrieva O.V.
Prognostic role of thrombus formation biomarkers in thromboembolic complications diagnostics in patients with malignant neoplasms
|
№8 / 2022
|
|
Khlevchuk N.E., Komelyagina N.A., Zhuravleva N.V., Egorova E.N., Solovyov A.N., Gavrilova E.S.
Pulmonary embolism after traumatic surgery: is there a connection? Clinical case
|
№2 (приложение) / 2022
|
|
Tarasova L.V., Dimitrieva O.V., Busalaeva E.I., Vasilieva N.P.
Pulmonary embolism as early manifestation of malignant neoplasm of the pancreas
|
№6 / 2020
|
|
Grigorieva A.Yu., Amineva N.V., Asoskova A.V.
Difficulties in diagnostics and treatment of recurrent pulmonary embolism in comorbid pathology: a case from practice
|
№4 / 2019
|
|
Shostak N.A., Klimenko A.A., Shemenkova V.S., Svet A.V.
Modern algorithm for the diagnosis of chronic thromboembolic pulmonary hypertension
|
№4 / 2019
|
|
Buryachkovskaya L.I., Lomakin N.V., Sumarokov A.B., Shirokov E.A.
Efficacy and safety of antithrombotic therapy [venous thrombosis and pulmonary artery thrombembolia]: scales and algorithms
|
№4 / 2019
|
|
E.A. Kochmareva, V.A. Kokorin, M.N. Aref'ev, V.A. Rusina, I.G. Gordeev
Risk factors for the development of obstructive shock in patients with pulmonary embolism
|
№3 / 2018
|
|
L.V. Kodzoyeva, A.N. Kuznetsov, A.A. Nekrasov
Underdiagnosis of early predictors of pulmonary embolism
|
№3 / 2015
|
Русский
